AMRUTANJANNSEAmrutanjan Health Care Limited· PharmaceuticalsMediumNeutral
Announced Fri, 8 May · 18:09 IST

Amrutanjan Health Care Limited has informed the Exchange regarding Appointment of Mr. Ramaswami Krishnan as Non- Executive Independent Director of the company w.e.f. May 08, 2026.

Management Changes View source PDF

AMRUTANJAN · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+1.5%1-day move
₹545.00
prior close
₹554.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-2.0-2.3-1.7-3.3+1.5+7.5+4.6+2.0+2.4+1.3+1.7+2.7-0.4
Up moveDown movePending
AI summary

Amrutanjan Health Care Limited's Board of Directors has approved the appointment of Mr. Ramaswami Krishnan as an Additional Director designated as Non-Executive Independent Director effective 8 May 2026 for a term of five years. Mr. Krishnan, 65, is a qualified CA, CS, and CWA with a Ph.D. and MBA degree, previously associated with Malladi Drugs and Pharmaceuticals Limited as Director Finance & Marketing and Company Secretary. The Board also approved the re-appointment of Mr. Muralidharan Swayambunathan as Non-Executive Independent Director for a second term of five years from 29 June 2026 to 28 June 2031. Both appointments are subject to shareholder approval.

Likely market impact

The appointment of a qualified independent director with finance and compliance expertise strengthens the board's governance, which is a positive signal for shareholders concerned about oversight and transparency.